compounded semaglutide with niacinamide – $149/mo FDA Drug Recalls and Warnings:

[2] Mazdutides phase II trial in adults with obesity or excess weight showed approximately 10-14% weight loss at 4 mg and 6 mg doses over 32 to 48 weeks, with ongoing phase III trials investigating higher doses and effects on type 2 diabetes

This is not a dilution strategy

Tirzepatide (Zepbound) for weight management follows the same initial titration as Mounjaro but with a maintenance dose of 15 mg weekly for maximum effect

Maintaining lean muscle mass is important because muscle helps regulate metabolism and overall metabolic health

FDA Approves Orforglipron, First GLP-1 Pill Without Time, Food, or Water Restrictions

Retatrutide is an investigational drug and is not FDA-approved as of April 2026